Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis.

Literature DB >> 28434357

Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis.

Marios Arvanitis¹, Steven Simon¹, Gloria Chan², Denise Fine³, Paula Beardsley³, Michael LaValley⁴, Daniel Jacobson^2,5, Clarissa Koch², John L Berk^1,2, Lawreen H Connors^2,6, Frederick L Ruberg^2,3.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2017 PMID： 28434357 PMCID： PMC5497748 DOI： 10.1080/13506129.2017.1295371

Source DB: PubMed Journal: Amyloid ISSN： 1350-6129 Impact factor: 7.141

× No keyword cloud information.

3 in total

1. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.

Authors: D R Jacobson; R D Pastore; R Yaghoubian; I Kane; G Gallo; F S Buck; J N Buxbaum
Journal: N Engl J Med Date: 1997-02-13 Impact factor: 91.245

Review 2. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis.

Authors: Pullakhandam Raghu; Bhattiprolu Sivakumar
Journal: Biochim Biophys Acta Date: 2004-12-01

3. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.

Authors: Selma F Mohammed; Sultan A Mirzoyev; William D Edwards; Ahmet Dogan; Donna R Grogan; Shannon M Dunlay; Veronique L Roger; Morie A Gertz; Angela Dispenzieri; Steven R Zeldenrust; Margaret M Redfield
Journal: JACC Heart Fail Date: 2014-04 Impact factor: 12.035

3 in total

8 in total

Review 1. Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.

Authors: Frederick L Ruberg; Martha Grogan; Mazen Hanna; Jeffery W Kelly; Mathew S Maurer
Journal: J Am Coll Cardiol Date: 2019-06-11 Impact factor: 24.094

Review 2. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.

Authors: Angelos G Rigopoulos; Muhammad Ali; Elena Abate; Abdel-Rahman Torky; Marios Matiakis; Mammad Mammadov; Hannes Melnyk; Alexander Vogt; Renato de Vecchis; Boris Bigalke; Walter Wohlgemuth; Sophie Mavrogeni; Michel Noutsias
Journal: Heart Fail Rev Date: 2019-07 Impact factor: 4.214

Review 3. Update on Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.

Authors: Caleb J Hood; Nicholas S Hendren; Rose Pedretti; Lori R Roth; Lorena Saelices; Justin L Grodin
Journal: Curr Heart Fail Rep Date: 2022-08-05

Review 4. New Advanced Imaging Parameters and Biomarkers-A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy.

Authors: Roxana Cristina Rimbas; Anca Balinisteanu; Stefania Lucia Magda; Simona Ionela Visoiu; Andrea Olivia Ciobanu; Elena Beganu; Alina Ioana Nicula; Dragos Vinereanu
Journal: J Clin Med Date: 2022-04-22 Impact factor: 4.964

Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis.

1. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.

Review 2. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis.

3. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.

Review 1. Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.

Review 2. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.

Review 3. Update on Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.

Review 4. New Advanced Imaging Parameters and Biomarkers-A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy.

5. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.

Review 6. Adipokine Retinol Binding Protein 4 and Cardiovascular Diseases.

7. Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma.

Review 8. Diagnosis of Transthyretin Amyloid Cardiomyopathy.